Search research articles
Contact Us
Filters
Showing results (161-170 of 971) with videos related to
Page
of 98
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 28, 2021
Reply
Mathias Jachs, Thomas Reiberger, Mattias Mandorfer
JHEP Reports : Innovation in Hepatology
|
December 6, 2024
Mechanisms and implications of recompensation in cirrhosis
Salvatore Piano, Thomas Reiberger, Jaime Bosch
Journal of Hepatology
|
June 5, 2024
Does encephalopathy with early onset after TIPS impact on mortality?
Lukas Hartl, Andrea Kornfehl, Thomas Reiberger
Wiener Klinische Wochenschrift
|
October 29, 2025
Reply to: comment on "Effectiveness of controlled-expansion transjugular intrahepatic portosystemic shunt (CX-TIPS) in an interdisciplinary setting at a large tertiary center"
Marlene Hintersteininger, Thomas Reiberger, Lukas Hartl
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2022
Reply
Georg Semmler, Thomas Reiberger, Bernhard Scheiner
Journal of Hepatology
|
March 23, 2023
Reply to: "3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta"
Mathias Jachs, Mattias Mandorfer, Thomas Reiberger
Journal of Hepatology
|
January 26, 2021
Reply to: "Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease"
Dalila Costa, Benedikt Simbrunner, Thomas Reiberger
Journal of Clinical and Experimental Hepatology
|
September 2, 2025
Recanalizing the Path Forward: Revisiting the Role of Portal Vein Recanalization With Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Portal Vein Thrombosis
Marlene Hintersteininger, Lukas Hartl, Thomas Reiberger
Alimentary Pharmacology & Therapeutics
|
August 8, 2022
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Cells
|
November 26, 2022
Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update
Peter Ferenci, Thomas Reiberger, Mathias Jachs
Page
of 98
Search research articles
Search
Showing results (161-170 of 971) with videos related to
Sort By:
Page
of 98
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 28, 2021
Reply
Mathias Jachs, Thomas Reiberger, Mattias Mandorfer
JHEP Reports : Innovation in Hepatology
|
December 6, 2024
Mechanisms and implications of recompensation in cirrhosis
Salvatore Piano, Thomas Reiberger, Jaime Bosch
Journal of Hepatology
|
June 5, 2024
Does encephalopathy with early onset after TIPS impact on mortality?
Lukas Hartl, Andrea Kornfehl, Thomas Reiberger
Wiener Klinische Wochenschrift
|
October 29, 2025
Reply to: comment on "Effectiveness of controlled-expansion transjugular intrahepatic portosystemic shunt (CX-TIPS) in an interdisciplinary setting at a large tertiary center"
Marlene Hintersteininger, Thomas Reiberger, Lukas Hartl
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 16, 2022
Reply
Georg Semmler, Thomas Reiberger, Bernhard Scheiner
Journal of Hepatology
|
March 23, 2023
Reply to: "3P and 5P models of limited value for the detection of clinically significant portal hypertension in patients with hepatitis delta"
Mathias Jachs, Mattias Mandorfer, Thomas Reiberger
Journal of Hepatology
|
January 26, 2021
Reply to: "Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease"
Dalila Costa, Benedikt Simbrunner, Thomas Reiberger
Journal of Clinical and Experimental Hepatology
|
September 2, 2025
Recanalizing the Path Forward: Revisiting the Role of Portal Vein Recanalization With Transjugular Intrahepatic Portosystemic Shunt in Cirrhotic Portal Vein Thrombosis
Marlene Hintersteininger, Lukas Hartl, Thomas Reiberger
Alimentary Pharmacology & Therapeutics
|
August 8, 2022
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer? Authors' reply
Mathias Jachs, Thomas Reiberger, Peter Ferenci
Cells
|
November 26, 2022
Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update
Peter Ferenci, Thomas Reiberger, Mathias Jachs
Page
of 98